maxim 4dMaxim raised the firm's price target on Nutex Health (NUTX) to $225 from $100 and keeps a Buy rating on the shares. The company's Q1 resultsMaxim downgraded Stardust Power (SDST) to Hold from Buy. The firm is citing a longer time for potential U.S. lithium brine suppliers to